Video

SLE classification criteria perform well in validation study

Publish date: June 22, 2018

 

REPORTING FROM THE EULAR 2018 CONGRESS

SOURCE: Aringer M et al. Ann Rheum Dis. 2018;77(Suppl 2):60. Abstract OP0020.

Pages

Recommended Reading

Hydroxychloroquine throws off Quantiferon-TB Gold results, study finds
MDedge Rheumatology
Idiopathic pulmonary fibrosis a ‘robust diagnosis’
MDedge Rheumatology
Cutaneous lupus: Switching antimalarials can delay immunosuppressive therapy
MDedge Rheumatology
Long-term follow-up most important for hydroxychloroquine retinal screening
MDedge Rheumatology
Pemphigus remission rate tops 80% with rituximab
MDedge Rheumatology
EULAR scientific program highlights spectrum of translational research
MDedge Rheumatology
Baricitinib shows potential as lupus treatment
MDedge Rheumatology
LLDAS shows potential as routine lupus treatment target
MDedge Rheumatology
FDA database reveals many rheumatic and musculoskeletal adverse events on immunotherapies
MDedge Rheumatology
Low vitamin D linked with DVT in lupus patients
MDedge Rheumatology